Devgen’s mission is to enable farmers to sustainably grow more food on less land, with less water, agrochemicals and labor.

Devgen uses advanced biotechnology and molecular breeding technology to make high yielding seeds and crop protection solutions with a superior environmental profile.

Devgen brings this technology to the market in the world’s major food and feed crops through two complementary strategies:

  • Licensing Devgen technology for use in corn, cotton and soy and selected other crops in exchange for R&D funding, and milestone and royalty payments.
  • Producing and selling its premium hybrid seeds in major field crops such as rice, sunflower, sorghum, and pearl millet, in the Indian subcontinent and S.E. Asia.

In its Crop Protection unit, Devgen develops a novel nematicide, an agro-chemical product that protects crops from damage by parasitic nematodes.

Incorporated in 1997, Devgen has offices in Ghent (Belgium), Singapore, Hyderabad (India) and Delaware (US) and employs more than 200 people.
Breaking news
Feb 11, 2010 - Opstart van Amakem, een nieuw Vlaams biotechbedrijf met focus op chronische aandoeningen

Feb 11, 2010 - Amakem, a new Flemish drug discovery company starts operations for treatments of major chronic diseases

Download the Semi-Annual Results 2009

(Dutch version)
IFRS Interim Report

(English version)
IFRS Interim Report

Download the Annual Report for 2008

Annual Report 2008
(Dutch version)
Annual Accounts 2008
Annual Brochure 2008

Annual Report 2008
(English version)
Annual Accounts 2008
Annual Brochure 2008

© Devgen 2010Disclaimer